UNSPSC 51111636: Enocitabine

This classification denotes a pyrimidine antagonist with the molecular formula C31H55N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9YVR68W306, chemically known as docosanamide,nucleoside deriv but generally known as enocitabine, which bears US NIH Compound Identifier 3228. European Medicines Agency schedules Enocitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06537MIG. The term ENOCITABINE is an International Non-Proprietary Name.

UNSPSC 51111636 Enocitabine is a Commodity code for a specialized pharmaceutical product — a nucleoside analog used in oncology treatment — that sees minimal recent solicitation activity in state and local procurement. The code nominally covers procurement of this specific chemotherapy agent, but state and local issuing bodies rarely issue standalone notices tagged to this granular pharmaceutical SKU; instead, they typically bundle individual drugs within broader pharmaceutical supply agreements, group purchasing organization (GPO) contracts, or hospital formulary management arrangements that use higher-tier UNSPSC family or class codes. No recent state or local contract opportunities appear in the available records tagged specifically to enocitabine procurement.

Because the source contains no identified recent opportunities, issuing-body patterns, geographic concentration, or representative solicitations under this code, this Commodity code does not present a current pursuit target for state and local business development activity. Firms supplying oncology pharmaceuticals should monitor higher-tier pharmaceutical supply codes (such as UNSPSC 51111500 Pharmaceutical preparations, or family-level codes covering medicinal chemicals and botanical products) where state health departments, Medicaid agencies, hospital systems, and correctional health services issue volume tenders and standing-order agreements that encompass enocitabine and related agents.